Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
暂无分享,去创建一个
M. Atkinson | E. Candelario-Jalil | R. Lloyd | H. Nick | Wenting Wu | R. V. Vander Heide | A. Pugliese | M. Campbell-Thompson | Verena van der Heide | D. Homann | A. Posgai | C. Evans-Molina | I. Kusmartseva | F. Syed | Changjun Yang | Marda S Jorgensen | S. Cechin | Jack L. Harbert | J. Paulsen | Paul Joseph | Xiaohan Tang | Farooq Syed
[1] Diane C. Saunders,et al. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells , 2020, Cell Metabolism.
[2] L. Prokunina-Olsson,et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor , 2020, Nature Genetics.
[3] B. Obermayer,et al. Human Lungs Show Limited Permissiveness for SARS-CoV-2 Due to Scarce ACE2 Levels But Strong Virus-Induced Immune Activation in Alveolar Macrophages , 2020, SSRN Electronic Journal.
[4] The Lancet Diabetes & Endocrinology. COVID-19 and diabetes: a co-conspiracy? , 2020, The Lancet Diabetes & Endocrinology.
[5] D. Maahs,et al. COVID-19 and Children With Diabetes—Updates, Unknowns, and Next Steps: First, Do No Extrapolation , 2020, Diabetes Care.
[6] J. Rosenbauer,et al. Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany? , 2020, Diabetes Care.
[7] N. Oliver,et al. New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. , 2020, Diabetes Care.
[8] K. Khunti,et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.
[9] K. Khunti,et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study , 2020, The Lancet Diabetes & Endocrinology.
[10] J. Skarbinski,et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization , 2020, Annals of Internal Medicine.
[11] J. Taneera,et al. Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors , 2020, Biology.
[12] D. Baralle,et al. A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection , 2020, bioRxiv.
[13] Michael A. Joseph,et al. The impact of obesity on COVID-19 complications: a retrospective cohort study , 2020, International Journal of Obesity.
[14] Kevin W. Ng,et al. Tissue-specific and interferon-inducible expression of non-functional ACE2 through endogenous retrovirus co-option , 2020, bioRxiv.
[15] P. Marchetti,et al. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature , 2020, bioRxiv.
[16] Z. Xia,et al. Obesity and mortality of COVID-19. Meta-analysis , 2020, Obesity Research & Clinical Practice.
[17] Colin Smith,et al. Tissue-specific tolerance in fatal Covid-19 , 2020, medRxiv.
[18] L. Marchand,et al. Type 1 diabetes onset triggered by COVID-19 , 2020, Acta Diabetologica.
[19] N. Goldman,et al. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care , 2020, Diabetes Research and Clinical Practice.
[20] S. Pittaluga,et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series , 2020, EClinicalMedicine.
[21] Duc-Huy T. Nguyen,et al. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids , 2020, Cell Stem Cell.
[22] R. V. Vander Heide,et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans , 2020, The Lancet Respiratory Medicine.
[23] Garry P. Nolan,et al. Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers , 2020, medRxiv.
[24] M. Aepfelbacher,et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.
[25] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[26] F. Giorgi,et al. Geographic and Genomic Distribution of SARS-CoV-2 Mutations , 2020, Frontiers in Microbiology.
[27] J. Connors,et al. COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.
[28] M. Diamond,et al. TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes , 2020, bioRxiv.
[29] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[30] A. Maitra,et al. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract , 2020, bioRxiv.
[31] Guang Hao,et al. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease , 2020, Cardiovascular research.
[32] C. Lindskog,et al. The protein expression profile of ACE2 in human tissues , 2020, bioRxiv.
[33] Qiu Zhao,et al. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia , 2020, Gastroenterology.
[34] Jian Chen,et al. COVID‐19 infection may cause ketosis and ketoacidosis , 2020, Diabetes, obesity & metabolism.
[35] B. Hanley,et al. Autopsy in suspected COVID-19 cases , 2020, Journal of Clinical Pathology.
[36] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[37] P. Liu,et al. Gross examination report of a COVID-19 death autopsy. , 2020, Fa yi xue za zhi.
[38] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[39] J. George,et al. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes , 2017, Genome research.
[40] Samuel L. Wolock,et al. A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and Intra-cell Population Structure. , 2016, Cell systems.
[41] Mauro J. Muraro,et al. A Single-Cell Transcriptome Atlas of the Human Pancreas , 2016, Cell systems.
[42] D. M. Smith,et al. Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes , 2016, Cell metabolism.
[43] Mauro J. Muraro,et al. De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data , 2016, Cell stem cell.
[44] E. Bonifacio,et al. Validation of a rapid type 1 diabetes autoantibody screening assay for community‐based screening of organ donors to identify subjects at increased risk for the disease , 2016, Clinical and experimental immunology.
[45] M. Atkinson,et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes , 2012, Diabetes/metabolism research and reviews.
[46] Jin-Kui Yang,et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.
[47] Nigel M. Hooper,et al. A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.
[48] Diane C. Saunders,et al. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in b Cells , 2020 .